搜索临床试验以:AMG 719
总计4606个结果
-
Aligos Therapeutics终止
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.尚未招聘
-
US Department of Veterans Affairs完全的
-
Hope Rugo, MDUniversity of California, San Francisco; Amgen终止
-
University of Alabama at Birmingham招聘中
-
Kristina LindemannUniversity Hospital of North Norway; Haukeland University Hospital; Sorlandet Hospital HF; St. Olavs...完全的
-
Amgen完全的血小板减少症 | 特发性血小板减少性紫癜 | 免疫性(特发性)血小板减少性紫癜 (ITP) 患者的血小板减少症 | 血小板减少性紫癜
-
McMaster UniversityHamilton Health Sciences Corporation; Centre for Evidence-Based Implementation完全的
-
Astellas Pharma IncSeagen Inc.; Agensys, Inc.完全的
-
National Cancer Institute (NCI)完全的未明确的儿童实体瘤,具体方案 | 继发性急性髓性白血病 | 复发性儿童急性淋巴细胞白血病 | 复发性儿童急性髓性白血病 | 急性未分化白血病美国
-
Ascentage Pharma Group Inc.HealthQuest Pharma Inc.完全的
-
Michael B. Atkins, MDBristol-Myers Squibb; Hoosier Cancer Research Network主动,不招人
-
Athersys, IncNational Heart, Lung, and Blood Institute (NHLBI)终止
-
ANRS, Emerging Infectious DiseasesUniversity College London Hospitals; Imperial College London; Medical Research Council; European... 和其他合作者主动,不招人
-
Central Hospital, Nancy, France完全的
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.招聘中
-
Bambino Gesù Hospital and Research InstituteMinistero della Salute, Italy未知
-
Arrowhead Pharmaceuticals主动,不招人
-
University of Illinois at ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Amgen完全的第 1 部分 - 晚期实体瘤 | 第 2 部分 - 晚期或转移性胃癌 | 第 2 部分 - 晚期或转移性 GEJ日本
-
Astellas Pharma China, Inc.Seagen Inc.主动,不招人